Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.85 Insider Own25.95% Shs Outstand21.84M Perf Week2.24%
Market Cap68.39M Forward P/E- EPS next Y-0.69 Insider Trans0.00% Shs Float18.48M Perf Month19.13%
Income-22.69M PEG- EPS next Q-0.19 Inst Own40.82% Short Float0.39% Perf Quarter18.61%
Sales6.48M P/S10.55 EPS this Y0.00% Inst Trans-8.86% Short Ratio2.11 Perf Half Y21.78%
Book/sh1.50 P/B1.83 EPS next Y15.85% ROA-73.26% Short Interest0.07M Perf Year15.13%
Cash/sh1.36 P/C2.01 EPS next 5Y- ROE-93.55% 52W Range1.81 - 3.85 Perf YTD-2.49%
Dividend Est.- P/FCF- EPS past 5Y68.14% ROI-63.03% 52W High-28.83% Beta0.98
Dividend TTM- Quick Ratio7.41 Sales past 5Y17.21% Gross Margin26.65% 52W Low51.38% ATR (14)0.15
Dividend Ex-Date- Current Ratio7.90 EPS Y/Y TTM63.22% Oper. Margin-373.26% RSI (14)62.62 Volatility6.03% 6.12%
Employees66 Debt/Eq0.04 Sales Y/Y TTM23.91% Profit Margin-350.35% Recom1.00 Target Price4.50
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q60.94% Payout- Rel Volume0.96 Prev Close2.49
Sales Surprise- EPS Surprise- Sales Q/Q21.95% EarningsMay 14 BMO Avg Volume33.76K Price2.74
SMA206.30% SMA5018.13% SMA2000.66% Trades Volume35,184 Change10.04%
Date Action Analyst Rating Change Price Target Change
Jan-07-16Initiated Rodman & Renshaw Buy $4
Mar-13-15Downgrade Oppenheimer Outperform → Perform
Nov-26-13Initiated Oppenheimer Outperform $6
May-28-24 08:53AM
May-14-24 10:53AM
May-07-24 07:00AM
Apr-03-24 08:59AM
07:00AM Loading…
Mar-26-24 07:00AM
Mar-07-24 10:09AM
Mar-06-24 12:53PM
Feb-28-24 07:00AM
Feb-12-24 07:00AM
Feb-05-24 11:27AM
Jan-31-24 07:00AM
Jan-03-24 07:00AM
Dec-20-23 07:00AM
07:00AM Loading…
Nov-27-23 07:00AM
Nov-07-23 09:12AM
Nov-06-23 08:11AM
Nov-02-23 08:00AM
Nov-01-23 02:19PM
Oct-30-23 09:21AM
Oct-12-23 07:00AM
Oct-03-23 07:00AM
Aug-31-23 08:00AM
Aug-08-23 07:00AM
Jul-25-23 08:00AM
Jun-26-23 08:00AM
May-18-23 08:00AM
May-16-23 07:00AM
08:00AM Loading…
May-15-23 08:00AM
May-12-23 04:05PM
May-05-23 08:00AM
May-01-23 08:00AM
Apr-27-23 08:00AM
Mar-30-23 07:00AM
Mar-20-23 08:00AM
Mar-02-23 08:00AM
Feb-14-23 08:00AM
Nov-28-22 08:00AM
Nov-15-22 04:05PM
Nov-08-22 07:00AM
Oct-25-22 08:00AM
Sep-13-22 04:05PM
Sep-08-22 09:00AM
Aug-09-22 07:00AM
Aug-02-22 08:00AM
Jul-14-22 08:00AM
Jun-09-22 08:00AM
Jun-02-22 08:00AM
May-10-22 07:30AM
Apr-28-22 07:30AM
Mar-16-22 04:05PM
Mar-08-22 07:30AM
Feb-28-22 07:00AM
Feb-22-22 04:30PM
Feb-15-22 08:00AM
Jan-27-22 08:00AM
Jan-18-22 08:11AM
Nov-22-21 06:02AM
Nov-09-21 07:30AM
Nov-03-21 04:05PM
Oct-26-21 08:30AM
Oct-13-21 08:30AM
Aug-10-21 07:00AM
Aug-04-21 08:30AM
Jul-23-21 08:30AM
Jun-02-21 08:04AM
May-27-21 08:00AM
May-24-21 05:07AM
May-21-21 08:30AM
May-14-21 06:00AM
May-12-21 06:00AM
May-11-21 06:30AM
May-10-21 04:05PM
May-06-21 06:00AM
May-04-21 04:15PM
Apr-29-21 06:00AM
Apr-19-21 06:00AM
Apr-15-21 07:49AM
Apr-14-21 04:05PM
Mar-22-21 07:53AM
Mar-09-21 06:30AM
Mar-08-21 10:11AM
Mar-02-21 06:00AM
Feb-24-21 06:00AM
Feb-09-21 06:00AM
Feb-08-21 04:05PM
Feb-04-21 08:30AM
Feb-03-21 08:32AM
Jan-26-21 06:30AM
Nov-29-20 02:33PM
Nov-11-20 07:14AM
Nov-09-20 06:30AM
Nov-03-20 07:53AM
Nov-02-20 06:30AM
Oct-13-20 06:30AM
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROUBIN GARY SDirectorNov 30 '23Buy2.5350,000126,540438,902Dec 04 04:15 PM